Aug. 26 at 2:35 AM
$AXGN one of the rare biotech companies that is positively cashflowing, huge margins and have alot of cash on hand. Plus the testimonies from people who received experimental treatments are all very positive. Not a big position for me 5000 shares to start but I came across this company while doing some research and liked what I found.
I think this company has alot of potential. Also the risk reward is positively convex- down 2 up 10 from here. Market cap only 650 million- an easy acquisition target for a pharma behemoth.
